Forward P/S Multiple: Axogen (AXGN)

AxoGen, Inc. (AXGN) is investing colossal funds into tissue engineering, driving a technological breakthrough in nerve regeneration. The GURU.Markets portal displays this chart, where the forward P/S valuation helps track capitalization, and 12.40 represents the latest level value. Stability is guaranteed by the absence of geopolitical risks, while an impeccable reputation among surgeons has solidified the brand's status as the industry gold standard.

axogeninc.com - AXGN Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Axogen Surgical (AXGN)

- market price and analyst price targets:

Price Chart Axogen|AXGN - Consensus Target

- company stock exchange capitalization indicators:

Market Capitalization Axogen Surgical|AXGN - Total Enterprise Value

- issuer book value statistics:

Book Value per Share Axogen|AXGN - Accounting Capitalization|Market Capitalization to Book Value Ratio axogeninc.com|AXGN - Company Total Asset Base

- debt and liquidity data:

- financial results and valuation multiples details:

AXGN - Company Net Income|Expected Profit AxoGen, Inc.|AXGN - Market Cap to Net Income Ratio|Projected Price to Earnings Axogen Corp|AXGN - PEG Multiple|EV/EBITDA Multiple Axogen Surgical|AXGN - Operating income before deduction of amortization|Earnings per share for the last twelve months Axogen|AXGN - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months axogeninc.com|AXGN - Net earnings per share growth this year|Earnings growth forecast for next year AxoGen, Inc.

- sales and revenue indicators:

AXGN - Company Total Revenue|Company Projected Revenue Axogen|AXGN - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Axogen Surgical

Fundamental company analysis:AXGN (Axogen)

Seamless cold chain operations during graft delivery provide AxoGen, Inc. (AXGN) with operational resilience. Analyzing the company's forward P/S chart, an investor can see how the market values the efficiency of these logistics through the lens of expected sales. This metric correlates current market capitalization with projected revenue, measuring the price reaction to future cash flows. A decline in this ratio relative to average values signals that the asset is undervalued.

Who AxoGen, Inc. competes with

Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Projected Price to Revenue|Bioventus Corp - Forward Price-to-Revenue Multiple|Forward P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - Forward P/S Multiple|Market Cap to Expected Sales Ratio blade.com SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|VANI: Forward P/S Multiple|Xtant Medical (XTNT) - Forward P/S Multiple|Forward Price-to-Revenue Multiple NMTC|Market Cap to Projected Revenue MODD (Modular Med)|Price-to-Projected Revenue Ratio Myomo, Inc (MYO)|COCH - Market Cap to Future Revenue Ratio|Forward P/S Multiple VVOS (Vivos Therapeutics)|Projected Price to Revenue envveno.com|SINTX Technologies - Forward P/S Multiple|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue AMIX|Forward Price-to-Revenue Multiple IVF|BBLG: Forward Price to Sales|Forward P/S Multiple AXNX|Market Cap to Expected Sales Ratio BIOLASE Inc.|Price-to-Projected Revenue Ratio Dynatronics DYNT|FNA: Market Cap to Projected Revenue|INVO Bio - Forward P/S Multiple